Pathway
Targeted agents in triple negative breast cancer
Schematic of the most relevant molecular pathways and targeted agents in tripe negative breast cancer (TNBC). Tyrosine kinase receptor is activated upon binding of growth factors leading to activat...
WP:5215
What the reference databases state
Statements
38 statements
38 statements · 1 reference database · Subject: Targeted agents in triple negative breast cancer · Sources: WikiPathways
- AKT1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- AKT1S1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- AKT2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- AKT3 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- AR participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- ARAF participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- BRAF participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- DEPTOR participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- EIF4EBP1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- GRB2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- HRAS participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- INPP4B participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
Show the remaining 26
- IRS1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- KRAS participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MAP2K1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MAP2K2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MAPK1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MAPK3 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MAPKAP1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MLST8 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- MTOR participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- NRAS participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PARP1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PARP2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PDK1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PIK3CA participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PIK3R1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PRR5L participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- PTEN participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- RAF1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- RICTOR participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- RPS6KB1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- RPTOR participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- SOS1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- SOS2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- TELO2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- TSC1 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only
- TSC2 participates in Targeted agents in triple negative breast cancerProteinWikiPathways WP5215Inferred only